Kwantum Bio-Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 171.85%
(FY 2023)
- Profit 143.97%
(FY 2023)
- Ebitda 28.00%
(FY 2023)
- Net Worth 21.98%
(FY 2023)
- Total Assets 35.79%
(FY 2023)
About Kwantum Bio-Chemicals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vrushali Kumbhar, Vikram Kumbhar, and Ramesh Kumbhar serve as directors at the Company.
- CIN/LLPIN
U15134PN2020PTC192118
- Company No.
192118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kwantum Bio-Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Kumbhar  | Director | 18-Jul-2020 | Current |
| Vrushali Kumbhar | Director | 18-Jul-2020 | Current |
| Ramesh Kumbhar | Director | 18-Jul-2020 | Current |
Financial Performance of Kwantum Bio-Chemicals.
Kwantum Bio-Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 171.85% increase. The company also saw a substantial improvement in profitability, with a 143.97% increase in profit. The company's net worth Soared by an impressive increase of 21.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kwantum Bio-Chemicals?
Unlock access to Kwantum Bio-Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kwantum Chemicals And Polymers Private LimitedActive 11 years 8 monthsVrushali Kumbhar, Vikram Kumbhar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kwantum Bio-Chemicals?
Kwantum Bio-Chemicals has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kwantum Bio-Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kwantum Bio-Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
